A PLACEBO-CONTROLLED, DOUBLE-BLIND, PARALLEL-GROUP, 24 MONTH STUDY TO EVALUATE THE EFFICACY AND SAFETY OF E2609 IN SUBJECTS DIAGNOSED WITH EARLY ALZHEIMER'S DISEASE

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)

Royall, Donald R

Funded by

EISAI INC.

Research Start Date

05/01/2018

Status

Active

Collaborative Project

Clinical Care

Drug Discovery

Aging

Neuroscience

Bioscience Research Panel